Conatus Pharmaceuticals Inc. (CNAT)

[biotech2010]

It won't happen, they don't promote the stock price, go back and read some of the articles about the company and you will find it.

Meanwhile, those of us who understood the potential of the company when the share price was $2 have already been rewarded with the likely potential of far greater profits going forward, both in the near term (Phase 2 start, NVS options exercise), medium term (Phase 2 trial data in 2018-19) and long term (eventual approval of emricasan for NASH Cirrhosis)